C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?

References

• Horning S J. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993; 20: 75–88
   PubMed Web of Science ®Google Scholar
• Peterson B A. Current treatment of follicular low-grade lymphomas. Semin Oncol 1999; 26: 2–11
   PubMed Web of Science ®Google Scholar
• Fisher R I, LeBlanc M, Press O W, Maloney D G, Unger J M, Miller T P. New treatment options have changed survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447–8452
   PubMed Web of Science ®Google Scholar
• Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005; 105: 1417–1423
   PubMed Web of Science ®Google Scholar
• Gallagher C J, Gregory W M, Jones A E, Stansfeld A G, Richards M A, Dhaliwal H S, et al. Follicular lymphoma prognostic factors for response and survival. J Clin Oncol 1986; 4: 1470–1480
   PubMed Web of Science ®Google Scholar
• Anon. Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia-lymphoma. Fifth International Workshop on Chromosomes in Leukemia-Lymphoma. Blood 1987; 70: 1554–1564
   PubMed Web of Science ®Google Scholar
• Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049
   PubMed Web of Science ®Google Scholar
• Yunis J J, Frizzera G, Oken M M, Mckenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 1987; 316: 79–84
   PubMed Web of Science ®Google Scholar
• Godon A, Moreau A, Talmant P, Baranger-Papot L, Genevieve F, Milpied N, et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 2003; 17: 255–259
   PubMed Web of Science ®Google Scholar
• Korsmeyer S J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999; 59: 1693s–1700s
   PubMed Web of Science ®Google Scholar
• McDonnell T J, Deane N, Platt F M, Nunez G, Jaeger U, Mckearn J P, et al. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57: 79–88
   PubMed Web of Science ®Google Scholar
• Knezevich S, Ludkovski O, Salski C, Lestou V, Chhanabhai M, Lam W, et al. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Leukemia 2005; 19: 659–663
   PubMed Web of Science ®Google Scholar
• Lossos I S, Alizadeh A A, Diehn M, Warnke R, Thorstenson Y, Oefner P J, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proct Natl Acad Sci USA 2002; 99: 8886–88891
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Alizadeh A A, Segraves R, Blesa D, Rubio-Moscardo F, Albertson D G, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003; 101: 3109–3117
   PubMed Web of Science ®Google Scholar
• Karsan A, Gascoyne R D, Coupland R W, Shepherd J D, Phillips G L, Horsman D E. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma 1993; 10: 433–441
   PubMed Web of Science ®Google Scholar
• Greer W L, Lee C L, Callanan M B, Zayed E, Sadek I. Case of acute lymphoblastic leukemia presenting with t(14;18)BCL2, t(8;14)/cMYC, and t(1;2)/FCGR2B. Am J Hematol 2003; 74: 112–118
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle V, Crawford A, Khokhar T, Laffan M, Matutes E, Fairhead S, et al. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). Leukemia 1991; 5: 83–87
   PubMed Web of Science ®Google Scholar
• Fiedler W, Weh H J, Zeller W, Fonatsch C, Hillion J, Larsen C, et al. Translocation (14;18) and (8;22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Ann Hematol 1991; 63: 282–287
   PubMed Web of Science ®Google Scholar
• Yano T, Jaffe E S, Longo D L, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758–767
   PubMed Web of Science ®Google Scholar
• Thangavelu M, Olopade O, Beckman E, Vardiman J W, Larson R A, McKeithan T W, et al. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer 1990; 2: 147–158
   PubMed Web of Science ®Google Scholar
• Au W Y, Horsman D E, Gascoyne R D, Viswanatha D S, Klasa R J, Connors J M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519–528
   PubMed Web of Science ®Google Scholar
• Voorhees P M, Carder K A, Smith S V, Ayscue L H, Rao K W, Dunphy C H. Follicular lymphoma with a Burkitt translocation – predictor of an aggressive clinical course. Arch Pathol Lab Med 2004; 128: 210–213
   PubMed Web of Science ®Google Scholar
• Nagai M, Ikeda K, Tasaka T, Irino S. Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan. Leukemia 1991; 5: 462–467
   PubMed Web of Science ®Google Scholar
• Kanda-Akano Y, Nomura K, Fujita Y, Horiike S, Nishida K, Nagai M, et al. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene. Leuk Lymphoma 2004; 45: 1559–1567
   PubMed Web of Science ®Google Scholar
• Donti E, Falini B, Giuseppe Pelicci P, Venti Donti G, Rosetti A, Martelli M, et al. Immunological and molecular studies in a case of follicular lymphoma with an extra chromosome 12 and t(2;8) translocation. Leukemia 1988; 2: 41–44
   PubMed Web of Science ®Google Scholar
• Juneja S, Lukeis R, Tan L, Cooper I, Szelag G, Parkin J D, et al. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations. Br J Haematol 1990; 76: 231–237
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Offit K, Parsa N Z, Condon M R, Chekka N, Murphy J P, et al. Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 1992; 15: 2124–2130
   Google Scholar
• E S Jaffe, Harris, N L, Stein, H, Vardiman, J W. World Health Organisation Classification of Tumours: Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, IARC Press. 2001; 162–165
   Google Scholar
• Bartlett N K, Rizeq M, Dorfman R F, Halpern J, Horning S J. Follicular large-cell lymphoma: intermediate or low grade?. J Clin Oncol 1994; 12: 1349–1357
   PubMed Web of Science ®Google Scholar
• Martin A R, Weisenburger D D, Chan W C, Ruby E I, Anderson J R, Vose J M, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995; 85: 3671–3678
   PubMed Web of Science ®Google Scholar
• Anderson J R, Vose J M, Bierman P J, Weisenberger D D, Sanger W G, Pierson J, et al. Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J Clin Oncol 1993; 11: 218–224
   PubMed Web of Science ®Google Scholar
• Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D, et al. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997; 15: 1654–1663
   PubMed Web of Science ®Google Scholar
• Kondo E, Ogura M, Kagami Y, Taji H, Miura K, Takeuchi T, et al. Assessment of prognostic factors in follicular lymphoma patients. Int J Hematol 2001; 73: 363–368
   PubMed Web of Science ®Google Scholar
• Katsumata N, Matsuno Y, Nakayama H, Takenaka T, Kobayashi Y, Takeyama K, et al. Prognostic factors and a predictive model of follicular lymphoma: a 25 year study at a single institution in Japan. Jpn J Clin Oncol 1996; 26: 445–454
   PubMed Web of Science ®Google Scholar
• Solal-Celigny P, Roy P, Colombat P, White J, Armitage J O, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258–1265
   PubMed Web of Science ®Google Scholar
• Horsman D E, Connors J M, Pantzar T, Gascoyne R D. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375–382
   PubMed Web of Science ®Google Scholar
• Viardot A, Barth T F, Moller P, Dohner H, Bentz M. Cytogenetic evolution of follicular lymphoma. Semin Cancer Biol 2003; 13: 183–190
   PubMed Web of Science ®Google Scholar
• Akasaka T, Lossos I S, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443–1448
   PubMed Web of Science ®Google Scholar
• Arcinas M, Heckman C A, Mehew J W, Boxer L M. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. Cancer Res 2001; 61: 5202–5206
   PubMed Web of Science ®Google Scholar
• Lossos I S, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 2003; 13: 191–202
   PubMed Web of Science ®Google Scholar
• Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel M N, et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 2007; 21: 515–523
   PubMed Web of Science ®Google Scholar
• Dunphy C H, van Deventer H W, Carder K J, Rao K W, Dent G A. Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant?. Arch Pathol Lab Med 2003; 127: 610–613
   PubMed Web of Science ®Google Scholar
• Anon. A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• de Jong D, Voetdijk B M, Van Ommen, Kluin-Nelemans J C, Beverstock G C, Kluin P M. Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production. J Exp Med 1989; 169: 613–624
   PubMed Web of Science ®Google Scholar
• Kanungo A, Medeiros L J, Abruzzo L V, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006; 19: 25–33
   PubMed Web of Science ®Google Scholar